Shanghai Lifts Rebate Cap For Urban Worker Health Insurance
This article was originally published in PharmAsia News
The maximum reimbursement amount of Shanghai’s urban employee health insurance will increase from RMB 280,000 to RMB 340,000 from April 2013 through March 2014.
You may also be interested in...
Sanofi has transformed the productivity of its R&D pipeline over the past several years, and late-stage clinical data readouts are expected in the second half of this year for new anticancer drugs, a candidate pemphigus therapy and a COVID-19 vaccine.
The psoriasis market is a tough one for bimekizumab to crack but UCB head of immunology Emmanuel Caeymaex believes the clinical package and investment in promotion will see the IL-17A and IL-17F inhibitor topple its rivals.
The EU marketing authorization application for Takeda's dengue vaccine candidate is no longer being fast-tracked. Also, five requests for accelerated assessment were decided on at the latest meeting of the European Medicines Agency's drug evaluation committee, the CHMP.